Post by FDA

🚨 Limited seats remain for in-person attendance! Don’t miss the FDA-CRCG hybrid workshop on BE Innovations for Generic Oral Products (May 5-6). Explore innovative and alternative BE pathways, biopredictive dissolution methods, BE approaches for oncology oral products, solutions for discontinued RLDs and missing reference standards, and nitrosamine-driven reformulation assessment strategies. Secure your spot: https://lnkd.in/gH6eBKMJ #OralGenerics #ComplexGenerics #FDA #RegulatoryScience